During the past decade, Ospedale Santa Maria della Misericordia conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 40 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 27 clinical trials were completed. i.e. 79.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Santa Maria della Misericordia" #1 sponsor was "Celgene" with 11 trials, followed by "National Cancer Institute, Naples" with 7 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 6 trials sponsored, "Gruppo Italiano Trapianto di Midollo Osseo" with 6 trials sponsored and "Heart Care Foundation" with 6 trials sponsored. Other sponsors include 125 different institutions and companies that sponsored additional 82 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Santa Maria della Misericordia" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator, "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "Regione Lombardia" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Santa Maria della Misericordia" are "Multiple Myeloma" (8 trials), "Atrial Fibrillation" (7 trials), "Breast Cancer" (7 trials), "Heart Failure" (6 trials) and "Leukemia" (5 trials). Many other conditions were trialed in "Ospedale Santa Maria della Misericordia" in a lesser frequency.

Most popular intervention types in "Ospedale Santa Maria della Misericordia" are "Drug" (117 trials), "Other" (20 trials), "Device" (16 trials), "Procedure" (12 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Dexamethasone" (8 trials), "Rituximab" (8 trials), "Cyclophosphamide" (6 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Santa Maria della Misericordia" are 148 trials for "All" genders, 17 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Santa Maria della Misericordia". undefined are not yet recruiting, 21 are recruiting, 30 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 76 completed trials in Ospedale Santa Maria della Misericordia, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Santa Maria della Misericordia, 4 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".